Europe — EMA

Otulfi (Ustekinumab)

Ustekinumab, the active ingredient in Otulfi, is a biologic presented as a for use. It treats moderate to severe plaque psoriasis and psoriatic arthritis in adults.

Ustekinumab

Request sourcing

Pack/s

What is Ustekinumab?

Ustekinumab, the active ingredient in Otulfi, is a biologic presented as a for use. It treats moderate to severe plaque psoriasis and psoriatic arthritis in adults. GNH USA supplies Otulfi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Ustekinumab used for?

Ustekinumab acts … … … … … ... … ... … ... .

- Psoriasis: … … ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →